Health ❯ Healthcare ❯ Adverse Events

Drug Safety

Semaglutide Gastrointestinal Effects Retatrutide Side Effects Patient Monitoring Clinical Study Results

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Takeda targets regulatory filings in fiscal 2026 after presenting full results at upcoming medical meetings.

Lilly to Launch Late-Stage Trials of Amylin Obesity Drug After 20% Weight Loss in Mid-Stage Study

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide